Performance, Efficacy, and Safety of Lubiprostone in Bowel Preparation Regimens: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

In 30 seconds

This systematic review and meta-analysis evaluated the efficacy and safety of lubiprostone as an adjunct to bowel preparation for colonoscopy in 1322 patients across eight randomized controlled trials. The study found that lubiprostone significantly increased the odds of achieving excellent bowel preparation (OR: 2.25, P < 0.0001) compared to control, with no significant difference in polyp detection rates.

Key findings

• Lubiprostone significantly increased the odds of excellent bowel prep (OR: 2.25, P < 0.0001).
• There was no significant difference in polyp detection rates between lubiprostone and control groups (OR: 1.27, P = 0.15).
• Colonoscopy duration was similar between lubiprostone and control groups (P = 0.17).
• Adverse event odds were comparable between both groups (P = 0.22).

Why it matters

Improving bowel preparation quality is crucial for effective colonoscopy, as inadequate preparation can lead to missed polyps. This study suggests that lubiprostone may enhance preparation quality without increasing adverse events.